• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒的3C样蛋白酶通过一般碱机制催化底物水解。

3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism.

作者信息

Huang Changkang, Wei Ping, Fan Keqiang, Liu Ying, Lai Luhua

机构信息

State Key Laboratory for Structural Chemistry of Unstable and Stable Species, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, China.

出版信息

Biochemistry. 2004 Apr 20;43(15):4568-74. doi: 10.1021/bi036022q.

DOI:10.1021/bi036022q
PMID:15078103
Abstract

SARS 3C-like proteinase has been proposed to be a key enzyme for drug design against SARS. Lack of a suitable assay has been a major hindrance for enzyme kinetic studies and a large-scale inhibitor screen for SARS 3CL proteinase. Since SARS 3CL proteinase belongs to the cysteine protease family (family C3 in clan CB) with a chymotrypsin fold, it is important to understand the catalytic mechanism of SARS 3CL proteinase to determine whether the proteolysis proceeds through a general base catalysis mechanism like chymotrypsin or an ion pair mechanism like papain. We have established a continuous colorimetric assay for SARS 3CL proteinase and applied it to study the enzyme catalytic mechanism. The proposed catalytic residues His41 and Cys145 were confirmed to be critical for catalysis by mutating to Ala, while the Cys145 to Ser mutation resulted in an active enzyme with a 40-fold lower activity. From the pH dependency of catalytic activity, the pK(a)'s for His41 and Cys145 in the wild-type enzyme were estimated to be 6.38 and 8.34, while the pK(a)'s for His41 and Ser145 in the C145S mutant were estimated to be 6.15 and 9.09, respectively. The C145S mutant has a normal isotope effect in D(2)O for general base catalysis, that is, reacts slower in D(2)O, while the wild-type enzyme shows an inverse isotope effect which may come from the lower activation enthalpy. The pK(a) values measured for the active site residues and the activity of the C145S mutant are consistent with a general base catalysis mechanism and cannot be explained by a thiolate-imidazolium ion pair model.

摘要

严重急性呼吸综合征(SARS)3C样蛋白酶已被认为是针对SARS进行药物设计的关键酶。缺乏合适的检测方法一直是酶动力学研究以及针对SARS 3CL蛋白酶进行大规模抑制剂筛选的主要障碍。由于SARS 3CL蛋白酶属于具有胰凝乳蛋白酶折叠的半胱氨酸蛋白酶家族(CB族中的C3家族),了解SARS 3CL蛋白酶的催化机制对于确定蛋白水解是通过类似胰凝乳蛋白酶的一般碱催化机制还是类似木瓜蛋白酶的离子对机制进行至关重要。我们建立了一种针对SARS 3CL蛋白酶的连续比色测定法,并将其应用于研究酶的催化机制。通过突变为丙氨酸,证实了所提出的催化残基His41和Cys145对催化至关重要,而Cys145突变为Ser产生了一种活性降低40倍的活性酶。根据催化活性对pH的依赖性,野生型酶中His41和Cys145的pK(a)值估计分别为6.38和8.34,而C145S突变体中His41和Ser145的pK(a)值分别估计为6.15和9.09。C145S突变体在D(2)O中对于一般碱催化具有正常的同位素效应,即在D(2)O中反应较慢,而野生型酶显示出反向同位素效应,这可能源于较低的活化焓。活性位点残基测得的pK(a)值和C145S突变体的活性与一般碱催化机制一致,无法用硫醇盐-咪唑鎓离子对模型来解释。

相似文献

1
3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism.严重急性呼吸综合征冠状病毒的3C样蛋白酶通过一般碱机制催化底物水解。
Biochemistry. 2004 Apr 20;43(15):4568-74. doi: 10.1021/bi036022q.
2
Enzymatic activity characterization of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer technique.利用荧光共振能量转移技术对严重急性呼吸综合征冠状病毒3C样蛋白酶进行酶活性表征。
Acta Pharmacol Sin. 2005 Jan;26(1):99-106. doi: 10.1111/j.1745-7254.2005.00010.x.
3
Steady-state and pre-steady-state kinetic evaluation of severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro cysteine protease: development of an ion-pair model for catalysis.严重急性呼吸综合征冠状病毒(SARS-CoV)3CL蛋白酶半胱氨酸蛋白酶的稳态和预稳态动力学评估:催化离子对模型的建立
Biochemistry. 2008 Feb 26;47(8):2617-30. doi: 10.1021/bi702107v. Epub 2008 Feb 1.
4
A mechanistic view of enzyme inhibition and peptide hydrolysis in the active site of the SARS-CoV 3C-like peptidase.严重急性呼吸综合征冠状病毒3C样蛋白酶活性位点中酶抑制和肽水解的机制性观点。
J Mol Biol. 2007 Aug 24;371(4):1060-74. doi: 10.1016/j.jmb.2007.06.001. Epub 2007 Jun 8.
5
Severe acute respiratory syndrome coronavirus 3C-like proteinase N terminus is indispensable for proteolytic activity but not for enzyme dimerization. Biochemical and thermodynamic investigation in conjunction with molecular dynamics simulations.严重急性呼吸综合征冠状病毒3C样蛋白酶N端对于蛋白水解活性必不可少,但对于酶的二聚化并非如此。结合分子动力学模拟的生化和热力学研究。
J Biol Chem. 2005 Jan 7;280(1):164-73. doi: 10.1074/jbc.M408211200. Epub 2004 Oct 26.
6
The unusual catalytic triad of poliovirus protease 3C.脊髓灰质炎病毒蛋白酶3C不同寻常的催化三联体。
Biochemistry. 2003 Jan 21;42(2):516-22. doi: 10.1021/bi027004w.
7
Only one protomer is active in the dimer of SARS 3C-like proteinase.在严重急性呼吸综合征3C样蛋白酶的二聚体中,只有一个原体具有活性。
J Biol Chem. 2006 May 19;281(20):13894-8. doi: 10.1074/jbc.M510745200. Epub 2006 Mar 24.
8
The catalysis of the SARS 3C-like protease is under extensive regulation by its extra domain.严重急性呼吸综合征(SARS)3C样蛋白酶的催化作用受到其额外结构域的广泛调控。
FEBS J. 2006 Mar;273(5):1035-45. doi: 10.1111/j.1742-4658.2006.05130.x.
9
Quaternary structure, substrate selectivity and inhibitor design for SARS 3C-like proteinase.严重急性呼吸综合征3C样蛋白酶的四级结构、底物选择性及抑制剂设计
Curr Pharm Des. 2006;12(35):4555-64. doi: 10.2174/138161206779010396.
10
Dissection study on the severe acute respiratory syndrome 3C-like protease reveals the critical role of the extra domain in dimerization of the enzyme: defining the extra domain as a new target for design of highly specific protease inhibitors.严重急性呼吸综合征3C样蛋白酶的剖析研究揭示了额外结构域在该酶二聚化中的关键作用:将额外结构域定义为设计高特异性蛋白酶抑制剂的新靶点。
J Biol Chem. 2004 Jun 4;279(23):24765-73. doi: 10.1074/jbc.M311744200. Epub 2004 Mar 22.

引用本文的文献

1
Strategy to overcome a nirmatrelvir resistance mechanism in the SARS-CoV-2 nsp5 protease.克服严重急性呼吸综合征冠状病毒2(SARS-CoV-2)非结构蛋白5(nsp5)蛋白酶中奈玛特韦耐药机制的策略。
Sci Adv. 2025 Jun 6;11(23):eadv8875. doi: 10.1126/sciadv.adv8875.
2
Dynamic Cap-Mediated Substrate Access and Potent Inhibitor Design of Monkeypox Virus I7L Protease.猴痘病毒I7L蛋白酶的动态帽介导底物进入及强效抑制剂设计
Adv Sci (Weinh). 2025 Jul;12(26):e2501625. doi: 10.1002/advs.202501625. Epub 2025 Apr 7.
3
Exploring covalent inhibitors of SARS-CoV-2 main protease: from peptidomimetics to novel scaffolds.
探索新型冠状病毒主要蛋白酶的共价抑制剂:从拟肽到新型骨架
J Enzyme Inhib Med Chem. 2025 Dec;40(1):2460045. doi: 10.1080/14756366.2025.2460045. Epub 2025 Feb 6.
4
Research Progress on the Structure and Function, Immune Escape Mechanism, Antiviral Drug Development Methods, and Clinical Use of SARS-CoV-2 M.严重急性呼吸综合征冠状病毒2 M蛋白的结构与功能、免疫逃逸机制、抗病毒药物研发方法及临床应用研究进展
Molecules. 2025 Jan 16;30(2):351. doi: 10.3390/molecules30020351.
5
3-chymotrypsin-like protease in SARS-CoV-2.SARS-CoV-2 中的 3-糜蛋白酶样蛋白酶。
Biosci Rep. 2024 Aug 28;44(8). doi: 10.1042/BSR20231395.
6
Potential therapeutic target identification in the novel 2019 coronavirus: insight from homology modeling and blind docking study.2019新型冠状病毒潜在治疗靶点的鉴定:同源建模与盲对接研究的见解
Egypt J Med Hum Genet. 2020;21(1):44. doi: 10.1186/s43042-020-00081-5. Epub 2020 Oct 2.
7
Sensitive detection of SARS-CoV-2 main protease 3CL with an engineered ribonuclease zymogen.用工程化核酶原对 SARS-CoV-2 主蛋白酶 3CL 进行灵敏检测。
Protein Sci. 2024 Apr;33(4):e4916. doi: 10.1002/pro.4916.
8
On Inactivation of the Coronavirus Main Protease.冠状病毒主蛋白酶的失活
J Chem Inf Model. 2024 Mar 11;64(5):1644-1656. doi: 10.1021/acs.jcim.3c01518. Epub 2024 Feb 29.
9
Identification of a Putative SARS-CoV-2 Main Protease Inhibitor through In Silico Screening of Self-Designed Molecular Library.通过自行设计的分子文库的计算机筛选鉴定出一种潜在的 SARS-CoV-2 主要蛋白酶抑制剂。
Int J Mol Sci. 2023 Jul 13;24(14):11390. doi: 10.3390/ijms241411390.
10
Comprehensive Understanding of the Kinetic Behaviors of Main Protease from SARS-CoV-2 and SARS-CoV: New Data and Comparison to Published Parameters.全面了解 SARS-CoV-2 和 SARS-CoV 的主要蛋白酶的动力学行为:新数据与已发表参数的比较。
Molecules. 2023 Jun 7;28(12):4605. doi: 10.3390/molecules28124605.